This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: The University of Texas System. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: The Innovations of Sourindra Maiti
Introduction
Sourindra Maiti is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of immunology through his innovative research and development of monoclonal antibodies. His work focuses on enhancing the detection and functionality of CAR-modified immune cells.
Latest Patents
Sourindra Maiti holds a patent for the Anti-CD19 scFv (FMC63) polypeptide. This patent provides monoclonal antibodies that detect CD 19 CAR-modified immune cells and CAR-modified immune cells, irrespective of the tumor-associated antigen they target. The methods of using these functional monoclonal antibodies include detection, quantification, activation, and selective propagation of CAR-modified immune cells.
Career Highlights
Maiti is affiliated with The University of Texas System, where he continues to advance his research in immunotherapy. His work has the potential to significantly impact cancer treatment and the development of targeted therapies.
Collaborations
Some of his notable coworkers include Laurence J N Cooper and Bipulendu Jena. Their collaborative efforts contribute to the ongoing research and development in the field of CAR T-cell therapy.
Conclusion
Sourindra Maiti's innovative work in the development of monoclonal antibodies showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic approaches in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile